CROT: A Drug Target / Disease Biomarker (G54677)

Target Name: CROT

NCBI ID: G54677

CROT

CROT: A Drug Target / Disease Biomarker

CROT (Ceramide Response Operator) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and liver. It is a key regulator of cell signaling and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of CROT is its role in cell signaling. CROT is a scaffold protein that helps to regulate the activity of other proteins in the cell. This is accomplished through a process called tyrosination, which involves the addition of a tyrosine molecule to a protein. Tyrosination is a critical process that helps to regulate the signaling pathways that are involved in cell growth, differentiation, and survival.

In addition to its role in cell signaling, CROT is also involved in the regulation of inflammation. Chronic inflammation is a major risk factor for a number of diseases, including heart disease, cancer, and neurodegenerative disorders. CROT has been shown to play a key role in the regulation of inflammation by helps to control the activity of immune cells and regulate the production of pro-inflammatory molecules.

One of the ways that CROT is involved in inflammation is through its role in the regulation of the production of pro-inflammatory cytokines. These cytokines, such as TNF-alpha, IL-1, and IL-6, are important molecules that help to orchestrate the immune response and contribute to the development of inflammatory diseases. CROT has been shown to help to regulate the production of these cytokines by helps to prevent their phosphorylation and subsequent activation.

Another way that CROT is involved in inflammation is through its role in the regulation of the production of immune cells. CROT helps to regulate the development and function of immune cells, including T cells and B cells. This is accomplished through a process called negative regulation, which involves the inhibition of the activity of a protein by another protein.

In addition to its role in inflammation, CROT is also involved in the regulation of cell signaling and the development of cancer. CROT has been shown to play a key role in the regulation of cell proliferation and the development of cancer. This is accomplished through a process called tyrosination, which involves the addition of a tyrosine molecule to a protein. Tyrosination is a critical process that helps to regulate the signaling pathways that are involved in cell growth, differentiation, and survival.

Overall, CROT is a protein that is involved in a number of important processes in the cell. Its role in cell signaling, inflammation, and cancer regulation makes it an attractive target for drug development. Further research is needed to fully understand the functions of CROT and its potential as a drug target.

Protein Name: Carnitine O-octanoyltransferase

Functions: Beta-oxidation of fatty acids. The highest activity concerns the C6 to C10 chain length substrate. Converts the end product of pristanic acid beta oxidation, 4,8-dimethylnonanoyl-CoA, to its corresponding carnitine ester

The "CROT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CROT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets